Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

Saved in:
Bibliographic Details
Published in:Leukemia 2021-02, Vol.35 (2), p.628-631
Main Authors: Stegelmann, Frank, Wille, Kai, Busen, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Döhner, Hartmut, Stadler, Rudolf, Döhner, Konstanze, Griesshammer, Martin
Format: Article
Language:English
Subjects:
45
45/22
45/77
631/67/1990/2331
692/308/575
692/699/1541/1990/2331
Adult
Aged
Aged, 80 and over
Antineoplastic Agents - adverse effects
Cancer Research
Care and treatment
Complications and side effects
Critical Care Medicine
Development and progression
Drug dosages
Female
Follow-Up Studies
Fusion Proteins, bcr-abl - genetics
Hematology
Humans
Hydroxyurea
Hydroxyurea - adverse effects
Intensive
Internal Medicine
Leg ulcers
Letter
Male
Medicine
Medicine & Public Health
Middle Aged
Myeloproliferative disorders
Myeloproliferative Disorders - drug therapy
Myeloproliferative Disorders - genetics
Myeloproliferative Disorders - pathology
Neoplasms
Oncology
Prognosis
Prospective Studies
Retrospective Studies
Skin diseases
Skin Diseases - chemically induced
Skin Diseases - pathology
Survival Rate
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4833-2a7e704026e8d3d6c8af44e7d24f24f585d8b42ad0075ec2065f2114cab9108e3
cites cdi_FETCH-LOGICAL-c4833-2a7e704026e8d3d6c8af44e7d24f24f585d8b42ad0075ec2065f2114cab9108e3
container_end_page 631
container_issue 2
container_start_page 628
container_title Leukemia
container_volume 35
creator Stegelmann, Frank
Wille, Kai
Busen, Hannah
Fuchs, Christiane
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
description
doi_str_mv 10.1038/s41375-020-0945-3
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8318877</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A655716423</galeid><sourcerecordid>A655716423</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4833-2a7e704026e8d3d6c8af44e7d24f24f585d8b42ad0075ec2065f2114cab9108e3</originalsourceid><addsrcrecordid>eNp1kt-K1DAUxoso7rr6AN5IQBC9yJqkaZrZC2F20FEY_-Dqdcikp9MsbVKTdnSe1Zcx3Vl3d0BpoJDz-z7Oyfmy7Cklp5Tk8nXkNC8LTBjBZMYLnN_LjikvBS6Kgt7PjomUJRYzxo-yRzFeEjIVxcPsKGeCCin4cfb7wm6cra3RbkA6Rm-sHqx3yNfIjIN24MeIdLWFEAHBFtwQ0U87NKjZVcH_2o0B9BkKEMc2VergO6RRH3zswQx2C8h5h60bIEza5KxbFIex2iHr0PniK56fryh2sNFXdLeD1id5a2sI-6vUQt_q2EX08uOXT68QRqm9NTS6racuhwbQEkKnHbq48l0GP_Y4oY-zB7VuIzy5_p9k39-9_bZ4j1eflx8W8xU2XOY5ZrqEknDCBMgqr4SRuuYcyorxOp1CFpVcc6YrQsoCDCOiqBml3Oj1jBIJ-Un2Zu_bj-sOKpPmDLpVfbCdDjvltVWHFWcbtfFbJXOaNlQmg-fXBsH_GCEO6tKPIb1UVIxLwWZ5IcUttdEtKOtqn8xMZ6NRc1EUJRWc5Yk6_QeVvgo6a7yD2qb7A8GLO4IGdDs00bfjtKt4CNI9aNJ2Y4D6ZkJK1JRHtc-jSnlUUx7VpHl292luFH8DmAC2B2IquQ2E29H_7_oHWuHuUw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486293586</pqid></control><display><type>article</type><title>Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN</title><source>Nexis UK</source><source>Springer Link</source><creator>Stegelmann, Frank ; Wille, Kai ; Busen, Hannah ; Fuchs, Christiane ; Schauer, Stefanie ; Sadjadian, Parvis ; Becker, Tatjana ; Kolatzki, Vera ; Döhner, Hartmut ; Stadler, Rudolf ; Döhner, Konstanze ; Griesshammer, Martin</creator><creatorcontrib>Stegelmann, Frank ; Wille, Kai ; Busen, Hannah ; Fuchs, Christiane ; Schauer, Stefanie ; Sadjadian, Parvis ; Becker, Tatjana ; Kolatzki, Vera ; Döhner, Hartmut ; Stadler, Rudolf ; Döhner, Konstanze ; Griesshammer, Martin ; German Study Group-MPN</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/s41375-020-0945-3</identifier><identifier>PMID: 32616864</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>45 ; 45/22 ; 45/77 ; 631/67/1990/2331 ; 692/308/575 ; 692/699/1541/1990/2331 ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents - adverse effects ; Cancer Research ; Care and treatment ; Complications and side effects ; Critical Care Medicine ; Development and progression ; Drug dosages ; Female ; Follow-Up Studies ; Fusion Proteins, bcr-abl - genetics ; Hematology ; Humans ; Hydroxyurea ; Hydroxyurea - adverse effects ; Intensive ; Internal Medicine ; Leg ulcers ; Letter ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Myeloproliferative disorders ; Myeloproliferative Disorders - drug therapy ; Myeloproliferative Disorders - genetics ; Myeloproliferative Disorders - pathology ; Neoplasms ; Oncology ; Prognosis ; Prospective Studies ; Retrospective Studies ; Skin diseases ; Skin Diseases - chemically induced ; Skin Diseases - pathology ; Survival Rate ; Tumors</subject><ispartof>Leukemia, 2021-02, Vol.35 (2), p.628-631</ispartof><rights>The Author(s) 2020</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4833-2a7e704026e8d3d6c8af44e7d24f24f585d8b42ad0075ec2065f2114cab9108e3</citedby><cites>FETCH-LOGICAL-c4833-2a7e704026e8d3d6c8af44e7d24f24f585d8b42ad0075ec2065f2114cab9108e3</cites><orcidid>0000-0003-2157-476X ; 0000-0003-3565-8315 ; 0000-0003-0607-6033</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32616864$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stegelmann, Frank</creatorcontrib><creatorcontrib>Wille, Kai</creatorcontrib><creatorcontrib>Busen, Hannah</creatorcontrib><creatorcontrib>Fuchs, Christiane</creatorcontrib><creatorcontrib>Schauer, Stefanie</creatorcontrib><creatorcontrib>Sadjadian, Parvis</creatorcontrib><creatorcontrib>Becker, Tatjana</creatorcontrib><creatorcontrib>Kolatzki, Vera</creatorcontrib><creatorcontrib>Döhner, Hartmut</creatorcontrib><creatorcontrib>Stadler, Rudolf</creatorcontrib><creatorcontrib>Döhner, Konstanze</creatorcontrib><creatorcontrib>Griesshammer, Martin</creatorcontrib><creatorcontrib>German Study Group-MPN</creatorcontrib><title>Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN</title><title>Leukemia</title><addtitle>Leukemia</addtitle><addtitle>Leukemia</addtitle><subject>45</subject><subject>45/22</subject><subject>45/77</subject><subject>631/67/1990/2331</subject><subject>692/308/575</subject><subject>692/699/1541/1990/2331</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Cancer Research</subject><subject>Care and treatment</subject><subject>Complications and side effects</subject><subject>Critical Care Medicine</subject><subject>Development and progression</subject><subject>Drug dosages</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Fusion Proteins, bcr-abl - genetics</subject><subject>Hematology</subject><subject>Humans</subject><subject>Hydroxyurea</subject><subject>Hydroxyurea - adverse effects</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Leg ulcers</subject><subject>Letter</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Myeloproliferative disorders</subject><subject>Myeloproliferative Disorders - drug therapy</subject><subject>Myeloproliferative Disorders - genetics</subject><subject>Myeloproliferative Disorders - pathology</subject><subject>Neoplasms</subject><subject>Oncology</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Retrospective Studies</subject><subject>Skin diseases</subject><subject>Skin Diseases - chemically induced</subject><subject>Skin Diseases - pathology</subject><subject>Survival Rate</subject><subject>Tumors</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kt-K1DAUxoso7rr6AN5IQBC9yJqkaZrZC2F20FEY_-Dqdcikp9MsbVKTdnSe1Zcx3Vl3d0BpoJDz-z7Oyfmy7Cklp5Tk8nXkNC8LTBjBZMYLnN_LjikvBS6Kgt7PjomUJRYzxo-yRzFeEjIVxcPsKGeCCin4cfb7wm6cra3RbkA6Rm-sHqx3yNfIjIN24MeIdLWFEAHBFtwQ0U87NKjZVcH_2o0B9BkKEMc2VergO6RRH3zswQx2C8h5h60bIEza5KxbFIex2iHr0PniK56fryh2sNFXdLeD1id5a2sI-6vUQt_q2EX08uOXT68QRqm9NTS6racuhwbQEkKnHbq48l0GP_Y4oY-zB7VuIzy5_p9k39-9_bZ4j1eflx8W8xU2XOY5ZrqEknDCBMgqr4SRuuYcyorxOp1CFpVcc6YrQsoCDCOiqBml3Oj1jBIJ-Un2Zu_bj-sOKpPmDLpVfbCdDjvltVWHFWcbtfFbJXOaNlQmg-fXBsH_GCEO6tKPIb1UVIxLwWZ5IcUttdEtKOtqn8xMZ6NRc1EUJRWc5Yk6_QeVvgo6a7yD2qb7A8GLO4IGdDs00bfjtKt4CNI9aNJ2Y4D6ZkJK1JRHtc-jSnlUUx7VpHl292luFH8DmAC2B2IquQ2E29H_7_oHWuHuUw</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Stegelmann, Frank</creator><creator>Wille, Kai</creator><creator>Busen, Hannah</creator><creator>Fuchs, Christiane</creator><creator>Schauer, Stefanie</creator><creator>Sadjadian, Parvis</creator><creator>Becker, Tatjana</creator><creator>Kolatzki, Vera</creator><creator>Döhner, Hartmut</creator><creator>Stadler, Rudolf</creator><creator>Döhner, Konstanze</creator><creator>Griesshammer, Martin</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2157-476X</orcidid><orcidid>https://orcid.org/0000-0003-3565-8315</orcidid><orcidid>https://orcid.org/0000-0003-0607-6033</orcidid></search><sort><creationdate>20210201</creationdate><title>Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN</title><author>Stegelmann, Frank ; Wille, Kai ; Busen, Hannah ; Fuchs, Christiane ; Schauer, Stefanie ; Sadjadian, Parvis ; Becker, Tatjana ; Kolatzki, Vera ; Döhner, Hartmut ; Stadler, Rudolf ; Döhner, Konstanze ; Griesshammer, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4833-2a7e704026e8d3d6c8af44e7d24f24f585d8b42ad0075ec2065f2114cab9108e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>45</topic><topic>45/22</topic><topic>45/77</topic><topic>631/67/1990/2331</topic><topic>692/308/575</topic><topic>692/699/1541/1990/2331</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Cancer Research</topic><topic>Care and treatment</topic><topic>Complications and side effects</topic><topic>Critical Care Medicine</topic><topic>Development and progression</topic><topic>Drug dosages</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Fusion Proteins, bcr-abl - genetics</topic><topic>Hematology</topic><topic>Humans</topic><topic>Hydroxyurea</topic><topic>Hydroxyurea - adverse effects</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Leg ulcers</topic><topic>Letter</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Myeloproliferative disorders</topic><topic>Myeloproliferative Disorders - drug therapy</topic><topic>Myeloproliferative Disorders - genetics</topic><topic>Myeloproliferative Disorders - pathology</topic><topic>Neoplasms</topic><topic>Oncology</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Retrospective Studies</topic><topic>Skin diseases</topic><topic>Skin Diseases - chemically induced</topic><topic>Skin Diseases - pathology</topic><topic>Survival Rate</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stegelmann, Frank</creatorcontrib><creatorcontrib>Wille, Kai</creatorcontrib><creatorcontrib>Busen, Hannah</creatorcontrib><creatorcontrib>Fuchs, Christiane</creatorcontrib><creatorcontrib>Schauer, Stefanie</creatorcontrib><creatorcontrib>Sadjadian, Parvis</creatorcontrib><creatorcontrib>Becker, Tatjana</creatorcontrib><creatorcontrib>Kolatzki, Vera</creatorcontrib><creatorcontrib>Döhner, Hartmut</creatorcontrib><creatorcontrib>Stadler, Rudolf</creatorcontrib><creatorcontrib>Döhner, Konstanze</creatorcontrib><creatorcontrib>Griesshammer, Martin</creatorcontrib><creatorcontrib>German Study Group-MPN</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stegelmann, Frank</au><au>Wille, Kai</au><au>Busen, Hannah</au><au>Fuchs, Christiane</au><au>Schauer, Stefanie</au><au>Sadjadian, Parvis</au><au>Becker, Tatjana</au><au>Kolatzki, Vera</au><au>Döhner, Hartmut</au><au>Stadler, Rudolf</au><au>Döhner, Konstanze</au><au>Griesshammer, Martin</au><aucorp>German Study Group-MPN</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><addtitle>Leukemia</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>35</volume><issue>2</issue><spage>628</spage><epage>631</epage><pages>628-631</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32616864</pmid><doi>10.1038/s41375-020-0945-3</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-2157-476X</orcidid><orcidid>https://orcid.org/0000-0003-3565-8315</orcidid><orcidid>https://orcid.org/0000-0003-0607-6033</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0887-6924
ispartof Leukemia, 2021-02, Vol.35 (2), p.628-631
issn 0887-6924
1476-5551
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8318877
source Nexis UK; Springer Link
subjects 45
45/22
45/77
631/67/1990/2331
692/308/575
692/699/1541/1990/2331
Adult
Aged
Aged, 80 and over
Antineoplastic Agents - adverse effects
Cancer Research
Care and treatment
Complications and side effects
Critical Care Medicine
Development and progression
Drug dosages
Female
Follow-Up Studies
Fusion Proteins, bcr-abl - genetics
Hematology
Humans
Hydroxyurea
Hydroxyurea - adverse effects
Intensive
Internal Medicine
Leg ulcers
Letter
Male
Medicine
Medicine & Public Health
Middle Aged
Myeloproliferative disorders
Myeloproliferative Disorders - drug therapy
Myeloproliferative Disorders - genetics
Myeloproliferative Disorders - pathology
Neoplasms
Oncology
Prognosis
Prospective Studies
Retrospective Studies
Skin diseases
Skin Diseases - chemically induced
Skin Diseases - pathology
Survival Rate
Tumors
title Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A03%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Significant%20association%20of%20cutaneous%20adverse%20events%20with%20hydroxyurea:%20results%20from%20a%20prospective%20non-interventional%20study%20in%20BCR-ABL1-negative%20myeloproliferative%20neoplasms%20(MPN)%20-%20on%20behalf%20of%20the%20German%20Study%20Group-MPN&rft.jtitle=Leukemia&rft.au=Stegelmann,%20Frank&rft.aucorp=German%20Study%20Group-MPN&rft.date=2021-02-01&rft.volume=35&rft.issue=2&rft.spage=628&rft.epage=631&rft.pages=628-631&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/s41375-020-0945-3&rft_dat=%3Cgale_pubme%3EA655716423%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4833-2a7e704026e8d3d6c8af44e7d24f24f585d8b42ad0075ec2065f2114cab9108e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2486293586&rft_id=info:pmid/32616864&rft_galeid=A655716423&rfr_iscdi=true